P210 Defining the minimal important difference for the visual analogue scale for dyspnoea in patients with malignant pleural effusions

P210 Defining the minimal important difference for the visual analogue scale for dyspnoea in patients with malignant pleural effusions

Detalles Bibliográficos
Autores principales:	Mishra, E, Corcoran, J, Hallifax, R, Stradling, J, Maskell, N, Rahman, N
Formato:	Journal article
Publicado:	BMJ Publishing Group 2013

Ejemplares similares

Defining the minimal important difference for the visual analogue scale assessing dyspnea in patients with malignant pleural effusions.
por: Mishra, E, et al.
Publicado: (2015)

Defining the minimal important difference for the visual analogue scale assessing dyspnea in patients with malignant pleural effusions.
por: Eleanor K Mishra, et al.
Publicado: (2015-01-01)

THE USE OF INDWELLING PLEURAL CATHETERS FOR THE MANAGEMENT OF NON-MALIGNANT RECURRENT PLEURAL EFFUSIONS
por: Bhatnagar, R, et al.
Publicado: (2012)

Clinically important associations of pleurodesis success in malignant pleural effusion: Analysis of the TIME1 data set
por: Mercer, RM, et al.
Publicado: (2019)

Modern management of malignant pleural effusions
por: Mercer, R, et al.
Publicado: (2016)

An unusual cause of progressive dyspnoea, pulmonary nodules and pleural effusions
por: Sudharsan Venkatesan, et al.
Publicado: (2024-01-01)

Biological markers of successful pleurodesis for malignant pleural effusion
por: Psallidas, I, et al.
Publicado: (2016)

Thoracic ultrasonography as a predictor of pleurodesis success in malignant pleural effusion
por: Corcoran, J, et al.
Publicado: (2017)

Thoracic ultrasound as an early predictor of pleurodesis success in malignant pleural effusion
por: Corcoran, J, et al.
Publicado: (2018)

Retrospective analysis of survival time in malignant pleural effusion requiring IPC insertion
por: Asciak, R, et al.
Publicado: (2017)

Biological markers of favourable prognosis and successful pleurodesis for malignant pleural effusion
por: Psallidas, I, et al.
Publicado: (2016)

Assessment and treatment of malignant pleural effusions: visual analogue scale, ultrasound and drainage
por: Mishra, EK
Publicado: (2013)

Malignant pleural effusion management: keeping the flood gates shut
por: Walker, S, et al.
Publicado: (2019)

Survival and pleurodesis outcome in patients with malignant pleural effusion – post-hoc analysis from the TIME-1 trial
por: Hassan, M, et al.
Publicado: (2018)

Indwelling pleural catheters for non-malignant effusions: a multicentre review of practice.
por: Bhatnagar, R, et al.
Publicado: (2014)

The palliation of malignant pleural effusions.
por: Bhatnagar, R, et al.
Publicado: (2012)

Breathlessness post-drainage predicts survival in patients with malignant pleural effusion
por: Mishra, E, et al.
Publicado: (2018)

ERS/EACTS statement on the management of malignant pleural effusions
por: Bibby, A, et al.
Publicado: (2018)

Management of malignant pleural effusion
por: McCracken, D, et al.
Publicado: (2018)

Randomised controlled trial of urokinase versus placebo for non-draining malignant pleural effusion
por: Mishra, E, et al.
Publicado: (2018)

Survival And Pleurodesis Response Markers In Malignant Pleural Effusion-The Promise Study
por: Psallidas, I, et al.
Publicado: (2018)

Ultrasound in predicting improvement in dyspnoea after therapeutic thoracentesis in patients with recurrent unilateral pleural effusion
por: Katrine Fjaellegaard, et al.
Publicado: (2024-12-01)

Thoracoscopic evaluation of the effect of tumour burden on the outcome of pleurodesis in malignant pleural effusion
por: Ellayeh, M, et al.
Publicado: (2021)

Objective thoracoscopic criteria in differentiation between benign and malignant pleural effusions
por: Ellayeh, M, et al.
Publicado: (2021)

P234 Patient and fluid characteristics associated with non-draining malignant pleural effusion
por: Mishra, E, et al.
Publicado: (2017)

Investigating suspected malignant pleural effusion.
por: Rahman, N, et al.
Publicado: (2007)

Survival in patients with malignant pleural effusion undergoing talc pleurodesis
por: Hassan, M, et al.
Publicado: (2019)

Thoracoscopic evaluation of the effect of tumour burden on the outcome of pleurodesis in malignant pleural effusion
por: Ellayeh, MA, et al.
Publicado: (2021)

Cost-effectiveness of indwelling pleural catheter compared with talc in malignant pleural effusion.
por: Olfert, J, et al.
Publicado: (2016)

ERS/EACTS statement on the management of malignant pleural effusions
por: Bibby, AC, et al.
Publicado: (2018)

Malignant pleural mesothelioma with resolution of pleural effusion
por: Sayaka Nishida, et al.
Publicado: (2023-11-01)

Derrame pleural neoplásico Malignant pleural effusion
por: Lisete Ribeiro Teixeira, et al.
Publicado: (2006-08-01)

Biomarkers of malignancy in pleural effusions
por: José M. Porcel, et al.
Publicado: (2024-10-01)

Chemotherapy should not be withheld from patients with an indwelling pleural catheter for malignant pleural effusion.
por: Morel, A, et al.
Publicado: (2011)

Chemotherapy should not be withheld from patients with an indwelling pleural catheter for malignant pleural effusion
por: Morel, A, et al.
Publicado: (2011)

Thoracic ultrasound in the diagnosis of malignant pleural effusion.
por: Qureshi, N, et al.
Publicado: (2009)

Standard pleural biopsy versus CT-guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: a randomised controlled trial.
por: Maskell, N, et al.
Publicado: (2003)

Chemotherapy does not increase the risk of pleural infection in patients managed with an indwelling pleural catheter for malignant pleural effusion
por: Morel, A, et al.
Publicado: (2010)

Summary for clinicians: clinical practice guideline for management of malignant pleural effusions
por: Reddy, C, et al.
Publicado: (2019)

Pleurodesis practice for malignant pleural effusions in five English-speaking countries: survey of pulmonologists.
por: Lee, Y, et al.
Publicado: (2003)